Nippon Shinyaku (4516) · InitiativeRestated
Early market penetration of new products through marketing combining digital and physical channels
First written in FY2021. 1 of 2 entries say "Restated". Latest entry: FY2023.
2entries
3years
0from disclosures
How it moved
Same theme, other companies
New Pharmaceutical Market Penetration Through Combined Digital and In-Person InitiativesA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2023RestatedAnnual report
「In the domestic pharmaceuticals business, we will seek early market penetration of new products by responding to changes in the healthcare delivery system and through marketing that combines digital and physical channels.」
The Company reconfirmed its focus on early market penetration of new products through marketing combining digital and physical channels. - FY2021First statedAnnual report
「In the domestic pharmaceuticals business, we will seek early market penetration of new products by responding to changes in the healthcare delivery system and through marketing that combines digital and physical channels.」
For the first time, the Company specifically presented marketing combining digital and physical channels as a means of achieving market penetration for new products in the domestic pharmaceuticals business.